Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 159

Sort by

Sort Order Select

Journal Articles

β2-Adrenergic Receptor Agonist Terbutaline Regulates Macrophage Polarization Via HMGB1 in Immune Thrombocytopenia

Qiuyu Guo, Ye-Jun Wu, Gao-Chao Zhang, Yu-Xiu Chen, Meng-Lin Li, Meng-Yu Xiao, Jian-Ying Zhou, Lu-Lu Wang, Meng-Tong Zang, Zhuo-Yu An, Hai-Xia Fu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2024) 144 (Supplement 1): 425.

https://doi.org/10.1182/blood-2024-203555

Published: 2024

Journal Articles

Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 2938.

https://doi.org/10.1182/blood-2024-204843

Published: 2024

Journal Articles

Decitabine Regulates the Function of Mesenchymal Stem Cells By Restoring MAGEA4-Mediated Apoptosis in Immune Thrombocytopenia

Xuan Cai, Jin Wu, Haixia Fu, Xiao-Hui Zhang

Blood (2024) 144 (Supplement 1): 2685.

https://doi.org/10.1182/blood-2024-201544

Published: 2024

Journal Articles

A Phase 1 Study Investigating the Safety and Efficacy of Danvatirsen As Monotherapy Followed By Combination with Venetoclax in Patients with Relapsed/Refractory MDS and AML

Blood (2024) 144 (Supplement 1): 4265.5.

https://doi.org/10.1182/blood-2024-208998

Published: 2024

Journal Articles

Comparison of Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation between Patients with ALL and AML

Yu-Cheng Bao, Xuan Cai, Xiao-Hui Zhang

Blood (2024) 144 (Supplement 1): 2128.

https://doi.org/10.1182/blood-2024-206587

Published: 2024

Journal Articles

Cigarette Smoking Is Associated with Worse Prognosis in MDS and Causes Inflammation and Hematopoietic Alterations in Murine Models

Tanya Verma, Divij Verma, Srabani Sahu, Kith Pradhan, Sakshi Jasra, Seyedeh Shareh Dehghani, Hui Zhang, Mason Spodek, Ritesh Aggarwal, Amit Verma, Dean Hosgood, Aditi Shastri, Yiyu Zou

Blood (2024) 144 (Supplement 1): 5645.

https://doi.org/10.1182/blood-2024-204251

Published: 2024

Journal Articles

Coagulation Biomarker Signature As a Novel Differential Diagnostic Tool for CRS/Icans and Infection Post-CAR-T Therapy

Xianying Yin, Ao-Ran Zhang, Yu-Tong Bao, Yu Wang, Lanping Xu, Xiao-Hui Zhang, Xiangyu Zhao, Xiaojun Huang, Meng Lv

Blood (2024) 144 (Supplement 1): 7219.

https://doi.org/10.1182/blood-2024-207496

Published: 2024

Journal Articles

Environmental Pollution Is Associated with Higher Risk MDS in a Diverse Urban Cohort and Triggers Inflammation in a Murine Models

Megha Verma, Matthew P Davidsohn, Srabani Sahu, Kith Pradhan, Seyedeh Shareh Dehghani, Sakshi Jasra, Ritesh Aggarwal, Hui Zhang, Michael Wysota, Divij Verma, Amit Verma, Dean Hosgood, Yiyu Zou, Aditi Shastri

Blood (2024) 144 (Supplement 1): 3200.

https://doi.org/10.1182/blood-2024-206324

Published: 2024

Journal Articles

A Phase 1 Study of AC676, a Novel BTK Chimeric Degrader, in Patients with B-Cell Malignancies

Michael T. Tees, David A. Bond, Nadia Khan, Farrukh T. Awan, Qiming Xu, Hui Zhang, Gladys Brown, Jennifer A. Woyach, Manish Patel

Blood (2024) 144 (Supplement 1): 4422.1.

https://doi.org/10.1182/blood-2024-194009

Published: 2024

Journal Articles

Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia

Wei Zhang, Li-xian Chang, Bei-bei Zhao, Dan-dan Shan, Bo-hao Tang, Fan Yang, Yue Zhou, Guo-xiang Hao, Yi Zheng, Ya-hui Zhang, John Van Den Anker, Xiaofan Zhu, Li Zhang, Wei Zhao

Blood (2023) 142 (Supplement 1): 1345.

https://doi.org/10.1182/blood-2023-181581

Published: 2023

Journal Articles

A STAT3 Degrader Demonstrates Pre-Clinical Efficacy in Venetoclax Resistant Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 2787.

https://doi.org/10.1182/blood-2023-186947

Published: 2023

Journal Articles

A Novel Risk Stratification Model for Cytogenetically Normal Acute Myeloid Leukemia with FLT3-ITD Mutation

Lei-Ming Cao, Ya-Lan Zhou, Ming-Yue Zhao, Li-Xia Liu, Hao Jiang, Ying-Jun Chang, Qian Jiang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Guo-Rui Ruan

Blood (2022) 140 (Supplement 1): 3218–3219.

https://doi.org/10.1182/blood-2022-169126

Published: 2022

Journal Articles

Pyrimethamine, a STAT3 Inhibitor, Synergizes with Venetoclax and Shows Efficacy in Hypomethylating Agent Resistant MDS and AML

Bianca L Rivera, Samarpana Chakraborty, Yang Shi, Hui Zhang, Gaurav S Choudhary, Shanisha Gordon, Kith Pradhan, Bowen Fu, Isidora Tosic, Rongbao Zhao, Mendel Goldfinger, Ioannis Mantzaris, Milagros Carbajal, Nandini Ramachandra, Marina Konopleva, David Frank, Yogenthiran Saunthararajah, Amit Verma, Aditi Shastri

Blood (2022) 140 (Supplement 1): 6892–6893.

https://doi.org/10.1182/blood-2022-163255

Published: 2022

Journal Articles

High Dimensional Mapping of Bone Marrow Immune Characteristics in Immune Thrombocytopenia

Feng-Qi Liu, Qingyuan Qu, Qi Chen, Hai-xia Fu, Kaiyan Liu, Xiao-hui Zhang

Blood (2022) 140 (Supplement 1): 2207–2208.

https://doi.org/10.1182/blood-2022-163389

Published: 2022

Journal Articles

Gut-Bile Acid-Immune Axis Regulates T Cell Homeostasis in the Pathogenesis of Immune Thrombocytopenia

Feng-Qi Liu, Qingyuan Qu, Yu-xiu Chen, Qi Chen, Meng-lin Li, Xueyan Sun, Hai-xia Fu, Kaiyan Liu, Xiao-hui Zhang

Blood (2022) 140 (Supplement 1): 8418–8419.

https://doi.org/10.1182/blood-2022-163458

Published: 2022

Journal Articles

Outcome and Molecular Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia Patients with MEF2D Fusions

Kai Sun, Wen-Min Chen, Xu Wang, Xiao-Su Zhao, Ling-Di Li, Yue Hao, Jun Wang, Nan Xu, Hao Jiang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Qian Jiang, Xiao Jun Huang, Ya-Zhen Qin

Blood (2022) 140 (Supplement 1): 11864–11865.

https://doi.org/10.1182/blood-2022-159866

Published: 2022

Journal Articles

Single-Cell Immune Landscape of Measurable Residual Disease in AML after Allogeneic Hematopoietic Stem Cell Transplantation

Xiao-Dong Mo, Weilong Zhang, Guomei Fu, Ying-Jun Chang, Xiao-hui Zhang, Lanping Xu, Yu Wang, Chen-Hua Yan, Meng-Zhu Shen, Qiu-Xia Wei, Changjian Yan, Xiao-jun Huang

Blood (2022) 140 (Supplement 1): 12908–12909.

https://doi.org/10.1182/blood-2022-165909

Published: 2022

Journal Articles

Machine Learning Algorithm As a Prognostic Tool for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation

Shuang Fan, Hao-Yang Hong, Xin-Yu Dong, Lan-Ping Xu, Xiao-hui Zhang, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Fengrong Wang, Jing-Zhi Wang, Kaiyan Liu, Meng-Zhu Shen, Xiao-jun Huang, Shen-Da Hong, Xiao-Dong Mo

Blood (2022) 140 (Supplement 1): 7691–7692.

https://doi.org/10.1182/blood-2022-165067

Published: 2022

Journal Articles

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Si-Qi Li, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Meng Lv, Fei-Fei Tang, Xiao-Dong Mo, Yan-Rong Liu, Kai-Yan Liu, Ying-Jun Chang, Xiao-Jun Huang

Blood (2022) 140 (5): 516–520.

https://doi.org/10.1182/blood.2021014604

Published: 2022

Includes: Supplemental data

Journal Articles

All- trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP

Ye-Jun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, Wen-Sheng Wang, Jia-Feng, He-Bing Zhou, Qiu-Sha Huang, Yun He, Hai-Xia Fu, Xiao-Lu Zhu, Qian Jiang, Hao Jiang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2022) 139 (3): 333–342.

https://doi.org/10.1182/blood.2021013393

Published: 2022

Includes: Supplemental data

NARROW

β2-Adrenergic Receptor Agonist Terbutaline Regulates Macrophage Polarization Via HMGB1 in Immune Thrombocytopenia

Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia

Decitabine Regulates the Function of Mesenchymal Stem Cells By Restoring MAGEA4-Mediated Apoptosis in Immune Thrombocytopenia

A Phase 1 Study Investigating the Safety and Efficacy of Danvatirsen As Monotherapy Followed By Combination with Venetoclax in Patients with Relapsed/Refractory MDS and AML

Comparison of Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation between Patients with ALL and AML

Cigarette Smoking Is Associated with Worse Prognosis in MDS and Causes Inflammation and Hematopoietic Alterations in Murine Models

Coagulation Biomarker Signature As a Novel Differential Diagnostic Tool for CRS/Icans and Infection Post-CAR-T Therapy

Environmental Pollution Is Associated with Higher Risk MDS in a Diverse Urban Cohort and Triggers Inflammation in a Murine Models

A Phase 1 Study of AC676, a Novel BTK Chimeric Degrader, in Patients with B-Cell Malignancies

Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia

A STAT3 Degrader Demonstrates Pre-Clinical Efficacy in Venetoclax Resistant Acute Myeloid Leukemia

A Novel Risk Stratification Model for Cytogenetically Normal Acute Myeloid Leukemia with FLT3-ITD Mutation

Pyrimethamine, a STAT3 Inhibitor, Synergizes with Venetoclax and Shows Efficacy in Hypomethylating Agent Resistant MDS and AML

High Dimensional Mapping of Bone Marrow Immune Characteristics in Immune Thrombocytopenia

Gut-Bile Acid-Immune Axis Regulates T Cell Homeostasis in the Pathogenesis of Immune Thrombocytopenia

Outcome and Molecular Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia Patients with MEF2D Fusions

Single-Cell Immune Landscape of Measurable Residual Disease in AML after Allogeneic Hematopoietic Stem Cell Transplantation

Machine Learning Algorithm As a Prognostic Tool for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

All- trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only